- Bromfenac as Adjunctive Treatment with Intravitreal Bevacizumab in Branch Retinal Vein Occlusion of Macular Edema
-
Yun JM, Cho YW, Moon JW
- KMID: 2470741
- J Korean Ophthalmol Soc.
- 2020 Feb;61(2):183-189.
- doi: 10.3341/jkos.2020.61.2.183
PURPOSE: To evaluate the effectiveness of 0.1% topical bromfenac as an adjunctive treatment with intravitreal bevacizumab (IVB) injection for branch retinal vein occlusion (BRVO) patients. METHODS: We retrospectively evaluated 68 eyes... -
- CITED
-
- Close
- SHARE
-
- Close
- Intraocular Pressure: Intravitreal Preservative-free Triamcinolone Injection in Diabetic Macular Edema and Branch Retinal Vein Occlusion
-
Lee CH, Seo YS
- KMID: 2470739
- J Korean Ophthalmol Soc.
- 2020 Feb;61(2):167-174.
- doi: 10.3341/jkos.2020.61.2.167
PURPOSE: To compare the intraocular pressure (IOP) in diabetic macular edema (DME) patients and macular edema associated with branch retinal vein occlusion (BRVO) patients after intravitreal preservative-free Triamcinolone injection. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes
-
Song SH, Baek SK, Lee MW, Lee YH
- KMID: 2469286
- Korean J Ophthalmol.
- 2020 Feb;34(1):46-55.
- doi: 10.3341/kjo.2019.0044
PURPOSE: To investigate the effect of 0.1% bromfenac sodium hydrate ophthalmic solution for prevention of macular edema after cataract surgery in patients with diabetes. METHODS: A retrospective analysis of 75 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Intravitreal Dexamethasone Implant for Diabetic Macular Edema According to Previous Responses to Bevacizumab
-
Kim D, Park DG, Ryu G, Sagong M
- KMID: 2468476
- J Korean Ophthalmol Soc.
- 2020 Jan;61(1):51-58.
- doi: 10.3341/jkos.2020.61.1.51
PURPOSE: To compare the efficacy of intravitreal dexamethasone implants according to previous response to bevacizumab treatment in patients with diabetic macular edema (DME). METHODS: Forty-nine eyes of 49 patients who received... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparision of Hyperreflective Foci after Treatment of Diabetic Macular Edema Patients between Intravitreal Injections
-
Kim M, Park K, Yi MY, Lee SJ
- KMID: 2468475
- J Korean Ophthalmol Soc.
- 2020 Jan;61(1):41-50.
- doi: 10.3341/jkos.2020.61.1.41
PURPOSE: To compare the outcomes in patients with diabetic macular edema (DME) treated with intravitreal dexamethasone implants and intravitreal bevacizumab injections. METHODS: A retrospective cohort study was designed using 66 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- New Method of Quantitative Analysis of Hard Exudate Using Optical Coherence Tomography: Application in Diabetic Macular Edema
-
Kim HR, Yoon CK, Kim HW, Pak KY
- KMID: 2459520
- Korean J Ophthalmol.
- 2019 Oct;33(5):399-405.
- doi: 10.3341/kjo.2019.0049
PURPOSE: In the present study, the volume of hard exudates (HEs) was quantitatively measured using optical coherence tomography (OCT) and the agreement and correlation with area of HEs in fundus... -
- CITED
-
- Close
- SHARE
-
- Close
- Subfoveal Choroidal Thickness Changes after Intravitreal Bevacizumab in Macular Edema Secondary to Retinal Vein Occlusion
-
Lee JY, Song SJ, Lee MY, Bae JH
- KMID: 2455456
- J Korean Ophthalmol Soc.
- 2019 Aug;60(8):740-747.
- doi: 10.3341/jkos.2019.60.8.740
PURPOSE: To determine changes in subfoveal choroidal thickness (SCT) after intravitreal injection of bevacizumab in eyes with macular edema secondary to retinal vein occlusion (RVO). METHODS: Forty-four patients treated with intravitreal... -
- CITED
-
- Close
- SHARE
-
- Close
- Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema
-
Yang J, Shin SJ, Suh JK, Tchoe H, Cho S, Kang MJ, Jee D
- KMID: 2453018
- J Korean Ophthalmol Soc.
- 2019 Jul;60(7):667-675.
- doi: 10.3341/jkos.2019.60.7.667
PURPOSE: This study investigated the optimal strategy to minimize budgetary constraints on National Health Insurance (NHI) services, while maximizing the number of diabetic macular edema (DME) patients who receive anti-vascular... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
-
Altintas A, Ilhan C
- KMID: 2448865
- Korean J Ophthalmol.
- 2019 Jun;33(3):259-266.
- doi: 10.3341/kjo.2018.0106
PURPOSE: To evaluate the changes in visual acuity (VA) and central macular thickness (CMT) after intravitreal dexamethasone (IVD) implantation in intravitreal bevacizumab (IVB) treatment-resistant cases with pseudophakic cystoid macular edema... -
- CITED
-
- Close
- SHARE
-
- Close
- Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema
-
Kim KT, Jang JW, Kang SW, Chae JB, Cho K, Bae K
- KMID: 2448864
- Korean J Ophthalmol.
- 2019 Jun;33(3):249-258.
- doi: 10.3341/kjo.2018.0100
PURPOSE: To evaluate the 1-year results of vitrectomy performed in combination with intraoperative dexamethasone implant for tractional and nontractional refractory diabetic macular edema (DME). METHODS: Thirteen eyes from 13 subjects who... -
- CITED
-
- Close
- SHARE
-
- Close
- Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review
-
Park KH, Kim YY, Jo YJ, Oh J, Lee JE, Lee JE, Park DH, Kang SW, Lee WK, Kim HK, Adena M, Tan J, Kim SD
- KMID: 2443206
- J Korean Med Sci.
- 2019 Apr;34(15):e118.
- doi: 10.3346/jkms.2019.34.e118
BACKGROUND: Limited data exist on real-world treatment patterns for diabetic macular edema (DME) in Korea. In this study, we investigated DME treatment patterns from 2009 to 2014 and the impact... -
- CITED
-
- Close
- SHARE
-
- Close
- Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema
-
Lee YJ, Kim M
- KMID: 2442626
- Korean J Ophthalmol.
- 2019 Apr;33(2):198-199.
- doi: 10.3341/kjo.2018.0079
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs
-
Ibrahim WS, Eldaly ZH, Saleh MG, Rateb MF, Aldoghaimy AH
- KMID: 2442616
- Korean J Ophthalmol.
- 2019 Apr;33(2):122-130.
- doi: 10.3341/kjo.2018.0037
PURPOSE: To evaluate the efficacy of switching to aflibercept in diabetic macular edema (DME) with suboptimal response to previous anti-vascular endothelial growth factor (anti-VEGF) injections. METHODS: A prospective interventional case series... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Dexamethasone Implantation in a Behcet's Disease Patient with Macular Edema, Vasculitis after Cataract Surgery
-
Lee JY, Ra H, Kim EC, Kang NY, Baek JW
- KMID: 2438081
- J Korean Ophthalmol Soc.
- 2019 Feb;60(2):195-200.
- doi: 10.3341/jkos.2019.60.2.195
PURPOSE: To report a case of macular edema and retinal vasculitis treated with intravitreal dexamethasone implantation in a Behcet's disease patient after cataract surgery. CASE SUMMARY: A 26-year-old male with Behcet's... -
- CITED
-
- Close
- SHARE
-
- Close
- Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema
-
Tchoe H, Shin SJ, Suh JK, Cho S, Yang J, Kang MJ, Jee D
- KMID: 2438073
- J Korean Ophthalmol Soc.
- 2019 Feb;60(2):144-151.
- doi: 10.3341/jkos.2019.60.2.144
PURPOSE: Intravitreal aflibercept, ranibizumab, bevacizumab, and dexamethasone are the most widely used drugs in the treatment of diabetic macular edema (DME). The aim of this study was to compare the... -
- CITED
-
- Close
- SHARE
-
- Close
- One-year Outcome of Intravitreal Dexamethasone Implant for Diabetic Macular Edema Patients
-
Park NH, Kwak HD, Yoon CK, Lee JE, Sagong M, Lee SJ, Lee JE, Kim KH, Kim HW
- KMID: 2438072
- J Korean Ophthalmol Soc.
- 2019 Feb;60(2):135-143.
- doi: 10.3341/jkos.2019.60.2.135
PURPOSE: The 1-year outcomes of intravitreal dexamethasone implants in diabetic macular edema (DME) patients were evaluated. METHODS: The medical records of 67 patients (70 eyes) with DME were reviewed retrospectively. All... -
- CITED
-
- Close
- SHARE
-
- Close
- Pars Plana Vitrectomy for Cystoid Macular Edema in a Retinitis Pigmentosa Patient
-
Choi YJ, Shin MH, Han YS, Seo SW, Yoo JM, Chung IY
- KMID: 2418508
- J Korean Ophthalmol Soc.
- 2018 Aug;59(8):790-796.
- doi: 10.3341/jkos.2018.59.8.790
PURPOSE: To report the first case of cystoid macular edema in a retinitis pigmentosa patient with pars plana vitrectomy. CASE SUMMARY: A 43-year-old female visited our hospital with visual disturbances of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Intravitreal Preservative-free Triamcinolone Injection for Refractory Macular Edema Secondary to Retinal Vein Occlusion
-
Lee CH, Jang MH, Seo YS
- KMID: 2418499
- J Korean Ophthalmol Soc.
- 2018 Aug;59(8):730-737.
- doi: 10.3341/jkos.2018.59.8.730
PURPOSE: To evaluate the efficacy of intravitreal preservative-free triamcinolone acetonide (Maqaid®) injection for the treatment of macular edema secondary to retinal vein occlusion (RVO) refractory to intravitreal bevacizumab injections. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment
-
Kaya M, Karahan E, Ozturk T, Kocak N, Kaynak S
- KMID: 2418150
- Korean J Ophthalmol.
- 2018 Aug;32(4):296-302.
- doi: 10.3341/kjo.2017.0117
PURPOSE: To evaluate the effectiveness of intravitreal injection of ranibizumab (IVR) in treating diabetic macular edema (DME) with serous retinal detachment (SRD) based on spectral domain optical coherence tomography (SD-OCT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and Risk Factors of Cystoid Macular Edema after Vitrectomy with Silicone Oil Tamponade for Retinal Detachment
-
Yang JY, Kim HK, Kim SH, Kim SS
- KMID: 2412799
- Korean J Ophthalmol.
- 2018 Jun;32(3):204-210.
- doi: 10.3341/kjo.2017.0050
PURPOSE: To investigate the incidence and risk factors of cystoid macular edema (CME) after silicone oil (SO) injection for retinal detachment. METHODS: Fifty-eight patients with retinal detachment treated by vitrectomy with... -
- CITED
-
- Close
- SHARE
-
- Close
